Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 289-293

  Mutapi, Francisca ^b   Ndhlovu, Patricia D ^b   Hagan, Paul ^b   Spicer, Janet T ^b   Mduluza, Takafira ^b   Michael R Turner, C ^b   Chandiwana, Steven K ^b   Woolhouse, Mark E J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PARASITE ANTIGEN; PRAZIQUANTEL;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CHILD; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MALE; PARASITE IDENTIFICATION; PARASITE PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; ZIMBABWE;

EID: 0031845502     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517456     Document Type: Article

References (17)

1. Harnett W. The antihelminthic action of praziquantel. Parasitol Today 1988;4:144-6.
2. Grogan JL, Kremsner PG, Vandam GJ, et al. Antischistosome IgG4 and IgE responses are affected differentially by chemotherapy in children versus adults. J Infect Dis 1996;173:1242-7.
3. Satti MZ, Lind P, Vennervald BJ, Sulaiman SM, Daffalla AA, Ghalib HW. Specific immunoglobulin measurements related to exposure and resistance to Schistosoma mansoni infection in Sudanese canal cleaners. Clin Exp Immunol 1996;106:45-54.
4. Gryseels D. Human resistance to Schistosoma infections: age or experience. Parasitol Today 1994;10:380-4.
5. Mota-Santos TA, Toledo MIM, Correa MCR, Correa-Oliveira R, Gazzineli G. Schistosomiasis from S. mansoni in mice: the relationship between acquired immunity and serum levels of lethal antibody. Parasite Immunol 1981;3:319-27.
6. Hagan P, Blumenthal UJ, Dunn D, Simpson AJG, Wilkins AH. Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 1991;349:243-5.
7. Rihet P, Demeure CE, Borgois A, Prata A, Dessien AJ. Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. Eur J Immunol 1991;21:2679-86.
8. Dunne DW, Butterworth AE, Fulford AJC, et al. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection. Eur J Immunol 1992;22:1483-94.
9. Mutapi F, Hagan P, Ndhlovu PD, Woolhouse MEJ. Comparison of humoral responses to Schistosoma haematobium in areas with high and low levels of infection. Parasite Immunol 1997;19:255-63.
10. Grzych JM, Grezel D, Xu CB, et al. IgA antibodies to a protective antigen in human Schistosomiasis mansoni. J Immunol 1993;150:527-35.
11. Langley JG, Kariuki HC, Hammersley AP, Ouma JH, Butterworth AE, Dunne DW. Human IgG subclass responses and subclass restriction to Schistosoma mansoni egg antigens. Immunology 1994; 83:651-8.
12. Khalife J, Dunne DW, Richardson BA, et al. Functional role of human IgG subclasses in eosinophil mediated killing of schistosomula of Schistosoma mansoni. J Immunol 1989;142:4422-7.
13. Fallen PG, Doenhoff MJ. Active immunisation of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel. Parasite Immunol 1995;17:261-8.
14. Brindley P, Sher A. The chemotherapeutic effect of praziquantel is against Schistosoma mansoni is dependent on host antibody response. J Immunol 1987;136:215-20.
15. De France T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J. Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40 - activated naive human B cells to secrete immunoglobulin A. J Exp Med 1992;175:671-82.
16. +) B cells to secrete IgG1 and IgG3. J Exp Med 1994;179:757-62.
17. Malisan F, Briere F, Bridon JM, et al. Interleukin-10 induces immunoglobulin G isotype switch recombination in human CD40-activated naive B lymphocytes. J Exp Med 1996;183:937-47.